Estarylla Kit
Product Images NDC 63629-2349

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Estarylla (NDC 63629-2349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart

A vertical effectiveness chart depicting different birth control methods categorized by pregnancy rates per 100 women per year. Methods with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Moderately effective methods include birth control pills, skin patches, and vaginal rings with hormones, followed by condoms and diaphragms. Less effective strategies include abstinence during fertile days, spermicide, withdrawal, and no birth control, which have the highest pregnancy rates.*

FDA Label Image

Estarylla-blister (Estarylla Blister)

Estarylla oral tablet kit label showing a 4-week calendar layout for daily medication intake. The label displays the brand name Estarylla and the active ingredients Norgestimate and ethinyl estradiol with dosages of 0.25 mg and 0.035 mg respectively. The visual includes arrows and shaded circles indicating pill-taking sequence for weeks 1 through 4.*

FDA Label Image

Figure 2

A forest plot displaying effect estimates (odds ratios or relative risks) with 95% confidence intervals from multiple studies related to contraceptive use. The horizontal axis shows effect estimates ranging from -1.5 to 2, with a vertical line at 1 as a reference. Individual study names and years are listed on the left, with their corresponding effect estimates and confidence intervals on the right.*

FDA Label Image

Label (Lbl636292349)

Estarylla kit with Norgestimate and Ethinyl Estradiol Tablets, USP, 0.25 mg/0.035 mg strength. The label shows a count of 84 tablets in three 28-tablet blisters, marked Rx only, and is relabeled by Bryant Ranch Prepack, Inc. Storage instructions and safety precautions are included.*

FDA Label Image

Structure Ee

Chemical structure of Ethinyl Estradiol, the active ingredient depicted in the image. The diagram shows the molecular framework with labeled elements and bonds representing the steroidal structure characteristic of this synthetic estrogen.*

FDA Label Image

Structure Norgestimate

Chemical structure of norgestimate, the active ingredient in Estarylla. The diagram shows the molecular structure with labeled carbon (CH) groups and functional groups typical of the synthetic progestin compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.